7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Treatment: Active ... disease • Check CXR ... #Management #Treatment
Cavitary Lesion with Air-Fluid Level on Chest XRay

70+ year old man with PMH of latent TB
man with PMH of latent ... TB s/p treatment ... #Cavitary #CXR ... #ChestXRay #Clinical ... #Pulmonary #Radiology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Treatment: Active ... disease • Check CXR ... #Management #Treatment
Primairy TB is usually clinically silent.
In 5% of infected individuals the immunity is inadequate and clinically
reactivation of the latent ... On the CXR it is ... with cavitaty formation ... #CXR #Tuberculosis ... #TB #Cavitary #
TB
This patient presented first with the CXR on the left.
The findings are:
Widespread ill-defined densities, which are
Cavity in the right ... reactivation of a latent ... #Clinical #Radiology ... #CXR #Tuberculosis ... #Cavitary #RadiologyAssistant
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for active or latent ... HIV-infected persons with clinical ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology